Related Experiment Videos
Alveolar and tissue surfactant pool sizes in humans
C M Rebello1, A H Jobe, J W Eisele
1Department of Pediatrics, Habor-UCLA Medical Center, UCLA School of Medicine 90509, USA.
American Journal of Respiratory and Critical Care Medicine
|September 1, 1996
Summary
Human lung surfactant, specifically saturated phosphatidylcholine (Sat-PC), does not change with age. The study found lower surfactant levels in humans compared to other species, potentially increasing lung injury susceptibility.
Area of Science:
- Pulmonary Medicine
- Biochemistry
Background:
- Surfactant quantities in human lung tissue and alveolar spaces are not well-documented.
- Surfactant plays a crucial role in maintaining lung function and preventing alveolar collapse.
Purpose of the Study:
- To investigate age-related changes in saturated phosphatidylcholine (Sat-PC) levels in human lungs.
- To quantify alveolar Sat-PC and surfactant protein-A (SP-A) concentrations in humans.
Main Methods:
- Analysis of 24 human lungs across a wide age range (13 months to 80 years).
- Measurement of Sat-PC in lung tissue relative to body weight, protein, and DNA.
- Lung lavage analysis to determine alveolar Sat-PC and SP-A concentrations.
Main Results:
- Sat-PC levels in lung tissue (per body weight, protein, or DNA) showed no significant variation with age.
- Alveolar Sat-PC and SP-A concentrations were found to be lower than previously reported in other species.
- Human lung surfactant pools appear relatively small.
Conclusions:
- Human lung Sat-PC content remains stable throughout adulthood.
- Lower surfactant levels in humans may indicate a heightened vulnerability to lung injury.
- Further research is needed to understand the implications of smaller human surfactant pools.